Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Clinical Genitourinary Cancer|August 21, 2009
Eosinophilic rash secondary to temsirolimusMona Gandhi, Timothy Kuzel, Mario LacoutureJournal of Personalized Medicine|January 8, 2015
A phase I study of high-dose calcitriol in combination with temozolomide for patients with metastatic melanomaErin Pettijohn, Brenda Martone, Alfred Rademaker, et al.ACG Case Reports Journal|October 19, 2017
Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?Madeline Bertha, Emanuelle Bellaguara, Timothy Kuzel, et al.Cureus|May 19, 2025
Drug-Induced Leukocytoclastic Vasculitis From an Unreported Source: DaptomycinJennifer K Priessnitz, Timothy Kuzel, Lindsay Ackerman, et al.Archives of Dermatology|June 19, 2008
Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphomaPedram Gerami, Steve Rosen, Timothy Kuzel, et al.Archives of Dermatology|March 21, 2002
Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphomaDebra Breneman, Madeleine Duvic, Timothy Kuzel, et al.Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.Research Square|June 19, 2023
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic targetMarina Ferrari, Li Wang, Luke Hoeppner, et al.Journal of Drugs in Dermatology : JDD|March 8, 2021
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis FungoidesChristina J Walker, Maria L Espinosa, Neha Mehta-Shah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology GroupStuart Hinton, Paul Catalano, Lawrence H Einhorn, et al.Pageof 3